Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay. (Q54082730)

24 May 2018

title

Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay. (English)

1 reference

24 May 2018

chronic lymphocytic leukemia

0 references

1 reference

1 reference

Bosanquet AG

1

1 reference

24 May 2018

Johnson SA

series ordinal

2

1 reference

24 May 2018

Richards SM

series ordinal

3

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

24 May 2018

British Journal of Haematology

published in

1 reference

24 May 2018

volume

106

1 reference

24 May 2018

issue

1

1 reference

24 May 2018

page(s)

71-77

1 reference

24 May 2018

Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

Ex vivo cytotoxic drug evaluation by DiSC assay to expedite identification of clinical targets: results with 8-chloro-cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

In vitro chemosensitivity of chronic lymphocytic leukaemia to purine analogues--correlation with clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

Phase I/II evaluation of pentostatin (2'-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

The DiSC assay. A cost-effective guide to treatment for chronic lymphocytic leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

Cytotoxic Drugs, Programmed Cell Death, and the Immune System: Defining New Roles in an Old Play

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01516.X

10.1046/J.1365-2141.1999.01516.X

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018